Science Applications (SAIC) | Financial Analysis & Statements
Science Applications International Corp. Mid-cap Technology
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jan 2026Income Metrics
Revenue
1.8B
Gross Profit
221.0M
12.63%
Operating Income
133.0M
7.60%
Net Income
85.0M
4.86%
EPS (Diluted)
$1.87
Balance Sheet Metrics
Total Assets
5.4B
Total Liabilities
3.9B
Shareholders Equity
1.5B
Debt to Equity
2.57
Cash Flow Metrics
Operating Cash Flow
226.0M
Free Cash Flow
250.0M
Revenue & Profitability Trend
Quarter Income Flow
Jan 31, 2026
Annual Income Flow
2026
Science Applications Income Statement From 2022 to 2026
| Metric | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | 7.3B | 7.5B | 7.4B | 7.7B | 7.4B |
| Cost of Goods Sold | 6.4B | 6.6B | 6.6B | 6.8B | 6.5B |
| Gross Profit | 872.0M | 892.0M | 872.0M | 888.0M | 859.0M |
| Gross Margin % | 12.0% | 11.9% | 11.7% | 11.5% | 11.6% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 350.0M | 339.0M | 373.0M | 374.0M | 344.0M |
| Other Operating Expenses | 1.0M | -8.0M | -3.0M | - | -1.0M |
| Total Operating Expenses | 351.0M | 331.0M | 370.0M | 374.0M | 343.0M |
| Operating Income | 521.0M | 561.0M | 502.0M | 514.0M | 516.0M |
| Operating Margin % | 7.2% | 7.5% | 6.7% | 6.7% | 7.0% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | 128.0M | 126.0M | 120.0M | 118.0M | 105.0M |
| Other Non-Operating Income | -6.0M | -7.0M | 238.0M | -21.0M | -53.0M |
| Pre-tax Income | 387.0M | 428.0M | 620.0M | 375.0M | 358.0M |
| Income Tax | 29.0M | 66.0M | 143.0M | 72.0M | 79.0M |
| Effective Tax Rate % | 7.5% | 15.4% | 23.1% | 19.2% | 22.1% |
| Net Income | 358.0M | 362.0M | 477.0M | 303.0M | 279.0M |
| Net Margin % | 4.9% | 4.8% | 6.4% | 3.9% | 3.8% |
| Key Metrics | |||||
| EBITDA | 664.0M | 692.0M | 643.0M | 663.0M | 682.0M |
| EPS (Basic) | $7.73 | $7.23 | $8.98 | $5.42 | $4.81 |
| EPS (Diluted) | $7.70 | $7.17 | $8.88 | $5.38 | $4.77 |
| Basic Shares Outstanding | 46300000 | 50100000 | 53100000 | 55300000 | 57600000 |
| Diluted Shares Outstanding | 46300000 | 50100000 | 53100000 | 55300000 | 57600000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Science Applications Balance Sheet From 2022 to 2026
| Metric | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 182.0M | 56.0M | 94.0M | 109.0M | 106.0M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 853.0M | 1.0B | 914.0M | 936.0M | 1.0B |
| Inventory | - | - | 3.0M | 71.0M | 64.0M |
| Other Current Assets | 22.0M | 20.0M | 27.0M | 23.0M | 21.0M |
| Total Current Assets | 1.2B | 1.2B | 1.1B | 1.2B | 1.3B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 193.0M | 164.0M | 152.0M | 158.0M | 209.0M |
| Goodwill | 6.6B | 6.5B | 6.6B | 6.8B | 7.0B |
| Intangible Assets | 761.0M | 779.0M | 894.0M | 1.0B | 1.1B |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 167.0M | 194.0M | 195.0M | 176.0M | 129.0M |
| Total Non-Current Assets | 4.2B | 4.1B | 4.2B | 4.3B | 4.5B |
| Total Assets | 5.4B | 5.2B | 5.3B | 5.5B | 5.7B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 500.0M | 631.0M | 567.0M | 624.0M | 612.0M |
| Short-term Debt | 19.0M | 313.0M | 77.0M | 31.0M | 148.0M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | - | - | - |
| Total Current Liabilities | 982.0M | 1.4B | 1.2B | 1.1B | 1.4B |
| Non-Current Liabilities | |||||
| Long-term Debt | 2.7B | 2.1B | 2.2B | 2.5B | 2.6B |
| Deferred Tax Liabilities | 104.0M | 24.0M | 28.0M | 0 | 43.0M |
| Other Non-Current Liabilities | 102.0M | 169.0M | 174.0M | 218.0M | 160.0M |
| Total Non-Current Liabilities | 2.9B | 2.3B | 2.4B | 2.7B | 2.8B |
| Total Liabilities | 3.9B | 3.7B | 3.5B | 3.8B | 4.1B |
| Equity | |||||
| Common Stock | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | 1.5B | 1.6B | 1.4B | 1.0B | 818.0M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 1.5B | 1.6B | 1.8B | 1.7B | 1.6B |
| Key Metrics | |||||
| Total Debt | 2.7B | 2.4B | 2.2B | 2.5B | 2.7B |
| Working Capital | 197.0M | -242.0M | -27.0M | 71.0M | -89.0M |
Balance Sheet Composition
Science Applications Cash Flow Statement From 2022 to 2026
| Metric | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 358.0M | 362.0M | 477.0M | 303.0M | 279.0M |
| Depreciation & Amortization | 149.0M | 140.0M | 142.0M | 157.0M | 165.0M |
| Stock-Based Compensation | 64.0M | 53.0M | 68.0M | 48.0M | 46.0M |
| Working Capital Changes | 28.0M | -44.0M | -70.0M | 78.0M | -31.0M |
| Operating Cash Flow | 681.0M | 501.0M | 594.0M | 564.0M | 492.0M |
| Investing Activities | |||||
| Capital Expenditures | - | - | - | - | - |
| Acquisitions | -203.0M | 10.0M | 348.0M | 0 | -247.0M |
| Investment Purchases | -20.0M | -14.0M | -8.0M | -7.0M | -9.0M |
| Investment Sales | 7.0M | 12.0M | 6.0M | 4.0M | 6.0M |
| Investing Cash Flow | -216.0M | 1.0M | 341.0M | -11.0M | -256.0M |
| Financing Activities | |||||
| Share Repurchases | -445.0M | -558.0M | -382.0M | -267.0M | -226.0M |
| Dividends Paid | -70.0M | -75.0M | -79.0M | -83.0M | -86.0M |
| Debt Issuance | 2.7B | 1.5B | 160.0M | 840.0M | 116.0M |
| Debt Repayment | -2.5B | -1.4B | -441.0M | -990.0M | -119.0M |
| Financing Cash Flow | -235.0M | -498.0M | -725.0M | -493.0M | -301.0M |
| Free Cash Flow | 577.0M | 458.0M | 369.0M | 507.0M | 482.0M |
| Net Change in Cash | 230.0M | 4.0M | 210.0M | 60.0M | -65.0M |
Cash Flow Trend
Science Applications Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
12.49
Forward P/E
8.90
Price to Book
2.82
Price to Sales
0.60
PEG Ratio
-1.94
Profitability Ratios
Profit Margin
4.93%
Operating Margin
9.09%
Return on Equity
23.27%
Return on Assets
6.34%
Financial Health
Current Ratio
1.20
Debt to Equity
180.40
Beta
0.30
Per Share Data
EPS (TTM)
$7.70
Book Value per Share
$34.09
Revenue per Share
$156.85
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| SAIC | 4.3B | 12.49 | 2.82 | 23.27% | 4.93% | 180.40 |
| International | 216.8B | 22.93 | 7.34 | 35.16% | 15.69% | 197.33 |
| Accenture plc | 109.7B | 14.61 | 3.51 | 24.76% | 10.61% | 25.47 |
| Aurora Innovation | 9.4B | - | 4.69 | -40.65% | -466.67% | 3.93 |
| Ingram Micro | 7.0B | 21.88 | 1.68 | 8.22% | 0.62% | 86.12 |
| Epam Systems | 6.5B | 19.66 | 1.95 | 10.34% | 6.92% | 3.91 |
Financial data is updated regularly. All figures are in the company's reporting currency.






